The results of the survival analysis showed that high FBL expression was positively correlated with a shorter overall survival (OS) (Figure 6E,G) and shorter disease-free survival (DFS) (Figure 6F,H) in hepatocellular carcinoma patients, and the differences were found to be statistically significant. The gene discussed is FBL; the disease is hepatocellular carcinoma.